Variant report
Variant | nsv976069 |
---|---|
Chromosome Location | chr13:95160348-95162152 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:95157773..95160608-chr13:95253108..95254690,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000152749 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536425892 | chr13:95160388-95160389 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs537839118 | chr13:95160402-95160403 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs553172437 | chr13:95160432-95160433 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs117529964 | chr13:95160454-95160455 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs9561582 | chr13:95160494-95160495 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs558222234 | chr13:95160517-95160518 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs56081055 | chr13:95160552-95160553 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs149182065 | chr13:95160553-95160554 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs189514498 | chr13:95160604-95160605 | Enhancers Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs529845370 | chr13:95160615-95160616 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181149307 | chr13:95160669-95160670 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560302205 | chr13:95160721-95160722 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9561583 | chr13:95160761-95160762 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs552442239 | chr13:95160764-95160765 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562680744 | chr13:95160821-95160822 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530797366 | chr13:95160829-95160830 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9561584 | chr13:95160840-95160841 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs567797116 | chr13:95160853-95160854 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186856673 | chr13:95160860-95160861 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536363001 | chr13:95160891-95160892 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142567616 | chr13:95160892-95160893 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369053880 | chr13:95160921-95160922 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9561586 | chr13:95160922-95160923 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs559196838 | chr13:95160926-95160927 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113491900 | chr13:95160937-95160938 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576374128 | chr13:95160940-95160941 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541797709 | chr13:95161070-95161071 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539678153 | chr13:95161079-95161080 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147601258 | chr13:95161090-95161091 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75621705 | chr13:95161091-95161092 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142056384 | chr13:95161094-95161095 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540331814 | chr13:95161118-95161119 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560035082 | chr13:95161157-95161158 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191666483 | chr13:95161169-95161170 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545712715 | chr13:95161171-95161172 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562779138 | chr13:95161222-95161223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531523110 | chr13:95161285-95161286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113740884 | chr13:95161437-95161438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550526477 | chr13:95161442-95161443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560957620 | chr13:95161454-95161455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530089536 | chr13:95161461-95161462 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145804289 | chr13:95161477-95161478 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7334716 | chr13:95161490-95161491 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs539208927 | chr13:95161493-95161494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560041330 | chr13:95161522-95161523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552527390 | chr13:95161561-95161562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73557889 | chr13:95161571-95161572 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs116045242 | chr13:95161573-95161574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554555259 | chr13:95161614-95161615 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7329277 | chr13:95161649-95161650 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 21811512 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:95159000-95160400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr13:95159000-95160400 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
3 | chr13:95159000-95160400 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
4 | chr13:95159000-95160800 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
5 | chr13:95159000-95161200 | Enhancers | Primary T helper cells fromperipheralblood | blood |
6 | chr13:95159200-95160400 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
7 | chr13:95159200-95160800 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
8 | chr13:95159200-95161200 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
9 | chr13:95159600-95160800 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
10 | chr13:95159600-95161800 | Enhancers | Dnd41 | blood |
11 | chr13:95159800-95160600 | Enhancers | Fetal Thymus | thymus |
12 | chr13:95159800-95160800 | Enhancers | Primary T cells from cord blood | blood |
13 | chr13:95160600-95161200 | Bivalent Enhancer | Fetal Thymus | thymus |
14 | chr13:95160600-95161200 | Bivalent Enhancer | Thymus | Thymus |
15 | chr13:95160600-95161800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr13:95161000-95161400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr13:95161000-95161400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr13:95161400-95166400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
19 | chr13:95161600-95166800 | Weak transcription | Aorta | Aorta |